4 completed, 1 terminated, 1 unknown. 2 Phase 1, 2 Phase 4, 1 Early Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 4 | 2 | Completed 1, Unknown 1 |
| Early Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Glucovance: new trials by email Literature Review of Glucovance trials Research Report on Glucovance
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Glyburide vs Glucovance in the Treatment of GDM Glyburide, Glucovance - Gestational Diabetes | Early Phase 1 | Terminated | Texas Tech University Health Sciences Center, El Paso | 7 | 2016-07-01 | 2020-10-12 |
| Oral Antidiabetic Agents in Pregnancy Metformin, Glyburide - Gestational Diabetes | Phase 4 | Unknown | Hospital de Clinicas de Porto Alegre | 80 | 2014-01-01 | 2014-03-19 |
| Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fasting Glyburide/Metformin 5 mg/500 mg Tablets, Glucovance® 5 mg/500 mg Tablets - Healthy | Phase 1 | Completed | Teva Pharmaceuticals USA | 60 | 2003-04-01 | 2024-08-19 |
| Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fed Glyburide/Metformin 5 mg/500 mg Tablets, Glucovance® 5 mg/500 mg Tablets - Healthy | Phase 1 | Completed | Teva Pharmaceuticals USA | 60 | 2003-02-01 | 2024-08-19 |
| A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes Glucovance (metformin HCl/glyburide), or Metformin HCl alone, or Glyburide alone. - Diabetes Mellitus, Non-Insulin-Dependent | Phase 4 | Completed | Bristol-Myers Squibb | 2002-02-01 | 2011-04-15 | |
| A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes. Glucovance (metformin HCl/glyburide), metformin HCl, glyburide - Diabetes Mellitus, Non-Insulin-Dependent | Phase 3 | Completed | Bristol-Myers Squibb | 2001-12-01 | 2011-04-15 |
Diabetes Mellitus, Type 2 (2) · Diabetes, Gestational (2) · Diabetes Mellitus (1)
Bristol-Myers Squibb (2) · Teva Pharmaceuticals USA (2) · Hospital de Clinicas de Porto Alegre (1) · Texas Tech University Health Sciences Center, El Paso (1)
United States (3) · Canada (2) · Brazil (1)
Eric Bicrell, M.D. (1) · Lisa E Moore, MD (1) · Maria Lucia R Oppermann, PhD Prf (1) · Richard Larouche, M.D. (1) · Vanessa K Genro, PhD (1)